Clinical Trial

Motiva Flora® Aesthetic Breast Recon® Clinical Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 26, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The present study will be based on a hybrid breast reconstruction approach with initial skin expansion using the Motiva Flora® Tissue Expander followed by a serial fat grafting session and a final step that includes the placement of a permanent breast implant Ergonomix2®.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-21; most recent amendment 2025-11-21.
Trial Details
NCT Number NCT06146231
Lead Sponsor Establishment Labs
Collaborators: NAMSA
Conditions Mammaplasty, Breast Cancer, Poland Syndrome
Enrollment 66 participants
Start Date 2023-08-18
Primary Completion 2026-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2025-11-26